Pfizer to seek COVID booster for healthy 5- to 11-year-olds
Pfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
Apr 14, 2022
0
5
Pfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
Apr 14, 2022
0
5
Almost one in three patients surviving a stroke of unknown cause have atrial fibrillation (AF) detectable using continuous cardiac monitoring, according to a study presented at the annual meeting of the European Heart Rhythm ...
Apr 5, 2022
0
5
Rates of atrial fibrillation (AF) recurrence following ablation increase incrementally according to body mass index, both in short- and long-term follow-up, according to a study presented at the annual meeting of the European ...
Apr 5, 2022
0
26
More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker testing, and this figure has increased over the last five years, reveal real-world data from a Spanish national registry ...
Mar 23, 2022
0
1
(HealthDay)—Use of artificial intelligence (AI)-based scheduling software to create more flexible work schedules may improve physician engagement and help reduce burnout, according to a study presented at the American Society ...
Feb 11, 2022
0
2
(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.
Jan 26, 2022
0
1
The resumption of holiday travel coupled with the rapidly spreading Omicron variant left Americans scrambling Wednesday to find at-home COVID tests, leading multiple major distributors to limit the number of kits per customer.
Dec 23, 2021
0
2
Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant.
Dec 20, 2021
0
60
The pandemic has been rumbling on for two years and is probably going to rumble on for years to come. And despite recent excitement about new drugs to treat COVID, it's still vaccines that will underpin each country's route ...
Nov 18, 2021
1
53
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for COVID-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
Nov 6, 2021
0
2